Agilent Technologies, Inc. has updated its segment reporting by moving its cell analysis business to the diagnostics and genomics segment, with historical financial data recast accordingly.
AI Assistant
AGILENT TECHNOLOGIES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.